Related Experiment Videos

Salbutamol: tablets, inhalational powder, or nebuliser?

Insights

Nebulized salbutamol provides the quickest relief for severe asthma attacks. For less severe cases, a combination of inhalational powder and tablets offers convenient and sufficient bronchodilation.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacology

Background:

  • Asthma management in children requires effective bronchodilator delivery.
  • Salbutamol is a primary treatment for acute asthma exacerbations.

Purpose of the Study:

  • To compare the efficacy and duration of bronchodilation from different salbutamol administration methods in children with severe asthma.

Main Methods:

  • A double-blind, triple-dummy, randomized trial involving 17 children with severe asthma.
  • Salbutamol was administered via nebulizer (4 mg), inhalational powder (400 mcg), or tablet (4 mg).
  • Peak expiratory flow rate (PEFR) was used to assess bronchodilation.

Main Results:

  • Nebulized salbutamol demonstrated the greatest bronchodilating effect (p<0.05).
  • Salbutamol tablets provided the longest duration of bronchodilation (p<0.0001).
  • Rapid onset of bronchodilation was observed across all administration routes.

Conclusions:

  • Nebulized salbutamol is most effective for severe asthma relief.
  • For less severe asthma, a combination of inhalational powder and tablets is a convenient and effective alternative.

Related Concept Videos